{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:57:33Z","timestamp":1790143053215,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0216600"],"award-info":[{"award-number":["2025ZD0216600"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473760"],"award-info":[{"award-number":["82473760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204184"],"award-info":[{"award-number":["82204184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117755","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:07:13Z","timestamp":1769270833000},"page":"117755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["MKOP002, a novel bifunctional \u03bc-\/\u03ba-opioid decapeptide with G protein-biased \u03bc-opioid agonism, exhibits antinociceptive and antipruritic activities"],"prefix":"10.1016","volume":"246","author":[{"given":"Shuyuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangtai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-6796","authenticated-orcid":false,"given":"Quan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.117755_b0010","first-page":"286","article-title":"Opioid analgesics for nociceptive cancer pain: a comprehensive review","volume":"74","author":"Abdel Shaheed","year":"2024","journal-title":"CA: Cancer J Clinicians"},{"issue":"6","key":"10.1016\/j.bcp.2026.117755_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1039\/D1MD00041A","article-title":"Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors","volume":"12","author":"De Neve","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bcp.2026.117755_b0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-med-011817-044739","article-title":"Use and misuse of opioids in chronic pain","volume":"69","author":"Volkow","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bcp.2026.117755_b0025","doi-asserted-by":"crossref","first-page":"109597","DOI":"10.1016\/j.neuropharm.2023.109597","article-title":"Cell-type specific molecular architecture for mu opioid receptor function in pain and addiction circuits","volume":"238","author":"Ochandarena","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117755_b0030","doi-asserted-by":"crossref","first-page":"835809","DOI":"10.3389\/fphar.2022.835809","article-title":"Agonist-promoted phosphorylation and internalization of the kappa opioid receptor in mouse brains: lack of connection with conditioned place aversion","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"39","key":"10.1016\/j.bcp.2026.117755_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp6038","article-title":"Kappa opioids inhibit spinal output neurons to suppress itch","volume":"10","author":"Sheahan","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.117755_b0040","doi-asserted-by":"crossref","first-page":"1583515","DOI":"10.3389\/fphar.2025.1583515","article-title":"Efficacy and safety of for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"16","author":"Pan","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/molecules28010346","article-title":"Design of \u03ba-opioid receptor agonists for the development of potential treatments of pain with reduced side effects","volume":"28","author":"Santino","year":"2023","journal-title":"Molecules (Basel, Switzerland)."},{"issue":"2","key":"10.1016\/j.bcp.2026.117755_b0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.120.000134","article-title":"Strategies for developing \u03ba opioid receptor agonists for the treatment of pain with fewer side effects","volume":"375","author":"Paton","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2026.117755_b0055","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/acs.jmedchem.2c01695","article-title":"Multitargeted opioid ligand discovery as a strategy to retain analgesia and reduce opioid-related adverse effects","volume":"66","author":"Smith","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117755_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.pmbts.2022.06.017","article-title":"Opioid signaling and design of analgesics","volume":"195","author":"Paul","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"14","key":"10.1016\/j.bcp.2026.117755_b0065","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/bph.13809","article-title":"Targeting multiple opioid receptors - improved analgesics with reduced side effects?","volume":"175","author":"G\u00fcnther","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bcp.2026.117755_b0070","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1021\/jm401290y","article-title":"Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors","volume":"56","author":"Provencher","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117755_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2008.05.003","volume":"55","author":"Matsumoto","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117755_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pbb.2012.12.026","article-title":"The mu\/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaine","volume":"104","author":"Smith","year":"2013","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.123.001870","article-title":"NCP, a dual Kappa and Mu Opioid Receptor Agonist, is a Potent Analgesic against Inflammatory Pain without reinforcing or Aversive Properties","volume":"389","author":"Huang","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"18","key":"10.1016\/j.bcp.2026.117755_b0090","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.15165","article-title":"Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour","volume":"177","author":"Brice-Tutt","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117755_b0095","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00213-016-4292-z","article-title":"The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel \u03ba agonist and \u03bc partial agonist, in mice","volume":"233","author":"Wang","year":"2016","journal-title":"Psychopharmacology"},{"issue":"22","key":"10.1016\/j.bcp.2026.117755_b0100","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1021\/acs.jmedchem.6b01181","article-title":"Structure-based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via \u03bc- and \u03ba-opioid receptors","volume":"177","author":"Xu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117755_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2018.08.039","article-title":"Systemic administration of the bifunctional opioid\/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain","volume":"837","author":"Li","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2026.117755_b0115","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of multifunctional and orally active cyclic peptide agonists of opioid\/neuropeptide ff receptors that produce potent, long-lasting, and peripherally restricted antinociception with diminished side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/acs.jmedchem.3c01347","article-title":"Structure-activity relationships of a novel cyclic hexapeptide that exhibits multifunctional opioid agonism and produces potent antinociceptive activity","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117755_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1213\/ANE.0000000000006266","article-title":"OCP002, a mixed agonist of opioid and cannabinoid receptors, produces potent antinociception with minimized side effects","volume":"136","author":"Xu","year":"2023","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0130","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.1038\/s41598-023-36245-7","article-title":"Formalin-evoked pain triggers sex-specific behavior and spinal immune response","volume":"13","author":"Pepino","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117755_b0135","doi-asserted-by":"crossref","first-page":"108178","DOI":"10.1016\/j.neuropharm.2020.108178","article-title":"VF-13, a chimeric peptide of VD-hemopressin(\u03b1) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects","volume":"175","author":"Xu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117755_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sjpain.2016.09.011","article-title":"Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain","volume":"14","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2017","journal-title":"Scand J Pain"},{"issue":"24","key":"10.1016\/j.bcp.2026.117755_b0145","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1111\/bph.70178","article-title":"A novel peptide-fentanyl conjugate with \u03bc-opioid and neuropeptide FF receptor agonism produces antinociception with limited side effects in male mice","volume":"182","author":"Li","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.bcp.2026.117755_b0150","doi-asserted-by":"crossref","first-page":"17138","DOI":"10.1021\/acs.jmedchem.3c02093","article-title":"All-hydrocarbon stapled peptide multifunctional agonists at opioid and neuropeptide ff receptors: highly potent, long-lasting brain permeant analgesics with diminished side effects","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bcp.2026.117755_b0155","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1021\/acschemneuro.2c00442","article-title":"OFP011 Cyclic peptide as a multifunctional agonist for opioid\/neuropeptide FF receptors with improved blood-brain barrier penetration","volume":"13","author":"Zhang","year":"2022","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2026.117755_b0160","doi-asserted-by":"crossref","first-page":"110157","DOI":"10.1016\/j.neuropharm.2024.110157","article-title":"Conorphin-66 produces peripherally restricted antinociception via the kappa-opioid receptor with limited side effects","volume":"261","author":"Xu","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117755_b0165","doi-asserted-by":"crossref","first-page":"176457","DOI":"10.1016\/j.ejphar.2024.176457","article-title":"The blockade of neuropeptide FF receptor 1 and 2 differentially contributed to the modulating effects on fentanyl-induced analgesia and hyperalgesia in mice","volume":"969","author":"Chen","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10194-019-0963-6","article-title":"Behavioral and cognitive animal models in headache research","volume":"20","author":"Vuralli","year":"2019","journal-title":"J. Headache Pain"},{"issue":"24","key":"10.1016\/j.bcp.2026.117755_b0175","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1021\/acs.jmedchem.0c01367","article-title":"Synthesis and biological characterization of cyclic disulfide-containing peptide analogs of the multifunctional opioid\/neuropeptide ff receptor agonists that produce long-lasting and nontolerant antinociception","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117755_b0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(02)00458-X","article-title":"Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence","volume":"115","author":"Kest","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1091581817750560","article-title":"Biochemical, oxidative, and physiological changes caused by acute exposure of fentanyl and its 3 analogs in rodents","volume":"37","author":"Yadav","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.bcp.2026.117755_b0190","doi-asserted-by":"crossref","first-page":"102212","DOI":"10.1016\/j.npep.2021.102212","article-title":"NOP01, a NOP receptor agonist, produced potent and peripherally restricted antinociception in a formalin-induced mouse orofacial pain model","volume":"91","author":"Xiao","year":"2022","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.bcp.2026.117755_b0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13880209.2018.1557698","article-title":"GABA and l-theanine mixture decreases sleep latency and improves NREM sleep","volume":"57","author":"Kim","year":"2019","journal-title":"Pharm. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117755_b0200","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/acs.jmedchem.0c02062","article-title":"Novel mixed NOP\/opioid receptor peptide agonists","volume":"64","author":"Pacifico","year":"2021","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2026.117755_b0205","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","article-title":"A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects","volume":"159","author":"Drieu la Rochelle","year":"2018","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.bcp.2026.117755_b0210","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","article-title":"Novel opioid analgesics and side effects","volume":"8","author":"Del Vecchio","year":"2017","journal-title":"ACS Chem. Nerosci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117755_b0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/ijms26051862","article-title":"Biased opioid receptor agonists: balancing analgesic efficacy and side-effect profiles","volume":"26","author":"Ju","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.117755_b0220","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1111\/nmo.13848","article-title":"Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid\/NPFF receptor agonist","volume":"32","author":"Xu","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.117755_b0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpain.2019.08.016","article-title":"Spinal DN-9, a peptidic multifunctional opioid\/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects","volume":"21","author":"Wang","year":"2020","journal-title":"J. Pain"},{"issue":"13","key":"10.1016\/j.bcp.2026.117755_b0230","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/jm950655o","article-title":"Effects of modifications of Residues in Position 3 of Dynorphin A(1\u221211)-NH2 on \u03ba Receptor Selectivity and Potency","volume":"39","author":"Lung","year":"1996","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2026.117755_b0235","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1021\/jm9901071","article-title":"A novel acetylated analogue of dynorphin A-(1-11) amide as a kappa-opioid receptor antagonist","volume":"42","author":"Wan","year":"1999","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2026.117755_b0240","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41401-021-00790-6","article-title":"Dezocine as a potent analgesic: overview of its pharmacological characterization","volume":"43","author":"Ye","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.117755_b0245","doi-asserted-by":"crossref","first-page":"43137","DOI":"10.1038\/srep43137","article-title":"Dezocine exhibits antihypersensitivity activities in neuropathy through spinal \u03bc-opioid receptor activation and norepinephrine reuptake inhibition","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117755_b0250","first-page":"145965","article-title":"Effects of combined opioids on pain and mood in mammals","volume":"2012","author":"Rech","year":"2012","journal-title":"Pain Res. Treat."},{"issue":"12","key":"10.1016\/j.bcp.2026.117755_b0255","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/exd.14669","article-title":"Role of kappa-opioid and mu-opioid receptors in pruritus: peripheral and central itch circuits","volume":"31","author":"Kim","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117755_b0260","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/molecules25112473","article-title":"On the role of peripheral sensory and gut mu opioid receptors: peripheral analgesia and tolerance","volume":"25","author":"F\u00fcrst","year":"2020","journal-title":"Molecules"},{"issue":"6813","key":"10.1016\/j.bcp.2026.117755_b0265","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.117755_b0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tibs.2020.10.002","article-title":"The life cycle of the Mu-opioid receptor","volume":"46","author":"Cuitavi","year":"2021","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2026.117755_b0275","doi-asserted-by":"crossref","first-page":"116686","DOI":"10.1016\/j.bcp.2024.116686","article-title":"Positive allosteric modulation of \u00b5-opioid receptor - a new possible approach in the pain management?","volume":"232","author":"Kr\u00f3l","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117755_b0280","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.tips.2017.08.004","article-title":"Designing Safer Analgesics via \u03bc-Opioid Receptor Pathways","volume":"38","author":"Chan","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2026.117755_b0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2019.03.006","article-title":"Bifunctional opioid receptor ligands as novel analgesics","volume":"151","author":"Cunningham","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117755_b0290","doi-asserted-by":"crossref","first-page":"106966","DOI":"10.1016\/j.phrs.2023.106966","article-title":"IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics","volume":"197","author":"Rehrauer","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117755_b0295","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56519","article-title":"Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site","volume":"10","author":"Uprety","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.bcp.2026.117755_b0300","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7619","key":"10.1016\/j.bcp.2026.117755_b0305","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2026.117755_b0310","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.117755_b0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11916-019-0773-1","article-title":"The utilization of Mu-opioid receptor biased agonists: oliceridine, an opioid analgesic with reduced adverse effects","volume":"23","author":"Urits","year":"2019","journal-title":"Curr. Pain Headache Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.117755_b0320","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0269881116689257","article-title":"Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents","volume":"31","author":"Altarifi","year":"2017","journal-title":"J. Psychopharmacol. (Oxford, England)."},{"key":"10.1016\/j.bcp.2026.117755_b0325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","article-title":"Biased agonism: lessons from studies of opioid receptor agonists","volume":"63","author":"Kelly","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2026.117755_b0330","doi-asserted-by":"crossref","first-page":"114785","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117755_b0335","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/molecules30030604","article-title":"Effects of biased analogues of the kappa opioid receptor Agonist, U50,488, in preclinical models of pain and side effects","volume":"30","author":"van de Wetering","year":"2025","journal-title":"Molecules (Basel, Switzerland)."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:33:26Z","timestamp":1778056406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":67,"alternative-id":["S0006295226000869"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117755","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MKOP002, a novel bifunctional \u03bc-\/\u03ba-opioid decapeptide with G protein-biased \u03bc-opioid agonism, exhibits antinociceptive and antipruritic activities","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117755"}}